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ABSTRACT 
The vascular disruption, blood vessel loss and cavitation that occur at spinal cord 
injury (SCI) epicentres in mice and rats are different, but few studies have compared 
the acute SCI response in the two species. This is of interest since key elements of 
the rat SCI response are shared with humans. In this study, we investigated acute 
SCI responses and characterised changes in pro- and anti-angiogenic factors and 
matrix deposition in both species. Cavitation was absent in mouse but the area of the 
lesion site was 21- and 27-fold larger at 8 and 15 days post lesion (dpl), respectively, 
in the rat compared to intact control. The absence of wound cavitation in the mouse 
was correlated with increased levels of immunoreactive pro-angiogenic, pro-matrix 
and pro-wound healing factors, e.g. laminin, matrix metalloproteinase-1 (MMP-1) and 
vascular endothelial growth factor-A (VEGF-A) within the wound, which were 6.0-, 
2.9-, and 2.8-fold, respectively, higher in the mouse compared to rats at 8 dpl. 
Increased axonal sparing was observed after DC injury, detected by higher levels of 
PKC-γ immunoreactivity in the dorsal column of mice compared to rats at both T7 
and T9 spinal segments. Despite similar post SCI deficits in plantar heat tests at 2 
hours after injury (1.4- and 1.6-fold lower than control mice and rats, respectively), by 
7 days the magnitude of these responses were comparable to sham-treated controls 
in both species, while no post-SCI changes in Von Frey hair filament test response 
were observed in either species. We conclude that the more robust 
angiogenesis/wound healing response in the mouse attenuates post-injury wound 
cavitation. Although the spinal cord functions that were monitored post-injury were 
similarly affected in both species, we suggest that the quality of the 
angiogenesis/wound healing response together with the diminished lesion size seen 
after mouse SCI may protect against secondary axon damage and create an 
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environment more conducive to axon sprouting/regeneration. These results suggest 
the potential therapeutic utility of manipulating the angiogenic response after human 
SCI.   
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INTRODUCTION 
Secondary damage after spinal cord injury (SCI) induces a cascade of injury 
responses including astrocyte reactivity and haematogenous immune cell 
immigration that contribute to ischemia, necrosis, oedema, apoptosis and cavitation, 
which compromise vascular and blood-brain barrier (BBB) integrity and disrupt 
motor, sensory and reflex pathways (Bazley et al., 2012; Fujiyoshi et al., 2007). New 
blood vessels formed in the wound by angiogenesis from pre-existing vessels, 
deliver the oxygen and nutrients that are essential to SCI wound repair (Oudega, 
2012). Attempts at therapeutic correction of the vascular disruption after SCI 
(Casella et al., 2006; Casella et al., 2002; Dray et al., 2009; Whetstone et al., 2003), 
have utilised pro-angiogenic factors including VEGF-A (Benton et al., 2009; Benton 
and Whittemore, 2003; Sundberg et al., 2011; Widenfalk et al., 2003), angiopoietins 
(Han et al., 2010; Herrera et al., 2010), FGF1 and 2 (De Laporte et al., 2011; 
Goldshmit et al., 2012; Nordblom et al., 2012) and TGF-β1 and 2 (De Laporte et al., 
2011; Han et al., 2010; Kohta et al., 2009). 
Although it is generally accepted that mice and rats exhibit different responses 
to SCI (Byrnes et al., 2010; Inman and Steward, 2003; Sroga et al., 2003), both 
species are commonly used as research tools in comparable studies of CNS repair 
after SCI. Differences between the two species include the inflammatory response; 
e.g. the increased numbers of T-cells peak at 3-7 days after injury in rats while, in 
mice, T-cell numbers peak later at 14 days (Byrnes et al., 2010; Sroga et al., 2003). 
Larger wound cavities develop in rats compared to mice, suggesting that wound 
healing and scarring responses are also different (Byrnes et al., 2010). Type I and II 
SCI wound cavities are recognised. The former are in continuity with the 
subarachnoid space and contain ECM proteins laminin and collagen, whereas the 
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latter contain mainly inflammatory cells, no ECM proteins and are discontinuous with 
the subarachnoid space (Fitch et al., 1999; Lagord et al., 2002). 
We hypothesised that, since wound cavitation after SCI is less developed in 
mice than in rats, mice have an accelerated acute wound healing response 
characterised by rapid re-vascularisation and matrix deposition. We used laminin 
immunoreactivity as a surrogate marker for this enhanced healing response and 
identified the time-point at which significant differences arose between these 
species. We then used the identified time-point to conduct a detailed investigation 
into the differences in pro-/anti-angiogenic and ECM molecule production in the two 
species after DC injury. Accordingly, we predicted that compared to rats, mice would 
have higher levels of pro-angiogenic VEGF-A, laminin and fibronectin expression in 
the acute phase of scarring and that the preservation of structure engendered by 
rapid healing and reduced cavitation in mice would correlate with enhanced levels of 
immunoreactivity for PKC-γ, indicative of enhanced neuropil sparing compared to 
rats. Furthermore, we predicted that the responses to thermal and mechanical stimuli 
would be more significantly affected by SCI in rats than in mice. 
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EXPERIMENTAL PROCEDURES 
Ethics statement 
This study was carried out in strict accordance to the UK Animals Scientific 
Procedures Act, 1986 and all procedures were licensed and approved by the UK 
Home Office. The protocols and experiments were also approved by the University 
of Birmingham Ethical Review Sub-Committee. All surgery was performed under 
inhalation anaesthesia using 5% Isofluorane (IsoFlo, Abbott Animal Health, North 
Chicago, IL, USA) for induction and 2% for maintenance. Animals were kept in 
environmentally controlled animal facilities at the University of Birmingham and every 
effort was made to minimise animal suffering. 
 
Experimental design  
Type of analysis N -  numbers End-points (days) 
Cavitation over time 6 (per time point/species) 0, 2, 8, 15 
Laminin timeline 6 (per time point/species) 0, 2, 8, 15 
Angiogenic/wound healing 
Immunohistochemistry 
6 (per time point/species) 0, 8 
Angiogenic/wound healing 
Western blot analysis 
6 (per time point/species) 0, 8 
Functional tests 6 (per species/group) -1 (day before), 0 (2hrs 
after surgery), 7, 14, 21 
 
Surgical procedures 
Three groups containing 6 adult female Sprague-Dawley rats (180-250g) or 6 adult 
female C57BL6 mice (20-25g) (Charles River, Margate, UK), comprised; Group 1 - 
sham operated (laminectomy only); Group 2 - dorsal column (DC) crush; and Group 
3 - intact controls. DC crush was performed as described by us previously (Ahmed et 
al., 2010; Lagord et al., 2002). Briefly, animals were anaesthetised using 5% 
isoflurane with 1.8l/min of oxygen, and given a subcutaneous injection of the 
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analgesic Buprenorphine before surgery. After laminectomy, DC were crushed 
bilaterally at the level of T8. The tips of calibrated watchmaker’s forceps separated 
by 1 mm were inserted through the dorsal cord meninges to a depth of 1 mm in rats 
and separated by 0.5mm in mice to a depth of 0.45 mm. These differences in injury 
sizes between rats and mice were calculated according to the Christopher & Dana 
Reeve Foundation spinal cord atlas for T8 level and represented equivalent DC 
injury sites in both species.    
Animals were randomly assigned, the identity of each animal was blinded by a 
second investigator, and randomly allocated to times of sacrifice post-SCI and 
portions of the cord at T8, encompassing the SCI site were harvested for analysis. 
For histology and immunohistochemistry, animals were killed in increasing 
concentrations of CO2 and intracardially perfused with 4% paraformaldehyde (PFA; 
TAAB Laboratories, Berkshire, UK). A 1 cm length of the spinal cord (0.5 mm either 
side of the T8 lesion epicentre) from both species was isolated, post-fixed for 2 hr in 
PFA, cryoprotected through a graded series of sucrose solutions and embedded in 
OCT mounting compound (TAAB Laboratories).  
In the first experiment, 6 animals/time-point were killed at 0, 2, 8 and 15 days 
post-lesion (dpl), to investigate lesion cavity development after injury. This study 
established that maximal differences in lesion cavity dimensions in rats and mice had 
developed at 8 dpl. Thus, further rats and mice were used to analyse the injury 
response at 8dpl in more detail by immunohistochemistry and western blotting.  
 
Haematoxylin and Eosin staining (H+E) 
Longitudinal/parasagittal 15 µm-thick sections of the cord through the lesion site 
were cut using a cryostat (Bright Instruments, Cambridgeshire, UK) and adhered 
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onto Superfrost Plus Slides (Fisher Scientific, Loughborough, UK). Sections were 
washed twice in PBS, immersed in Harris’s Haematoxylin (BDH, Poole, UK) for 5 
min and washed in tap water. Sections were then immersed in Eosin (BDH) for 1 
min, washed in tap water, dehydrated through a graded series of alcohols and 
cleared using 2 changes of Histoclear (National Diagnostics, Atlanta, USA) for 1 and 
3 min, respectively. Coverslips were mounted in Vectamount (Vector Laboratories, 
Peterborough, UK), viewed under a Zeiss Axioplan 2 light microscope and images 
captured using an Axiocam HRc run from Axiovision 4 software (all from Zeiss, 
Hertfordshire, UK).  
 
Immunohistochemistry 
Sections that contained only the lesion area were thawed for 30 min at room 
temperature and before proceeding with immunohistochemistry; a second 
investigator blinded the identity of each section. Randomised sections were then 
washed twice in PBS, permeabilised in 0.1% Triton X-100 in PBS for 10 min and 
then washed three times in PBS before blocking non-specific binding with PBS 
containing 3% BSA (Sigma) and 0.5% Tween 20 (Sigma) for 30 min at room 
temperature (RT). Sections were incubated with the appropriate primary antibody 
(Table 1), diluted in blocking solution and incubated overnight at 4⁰C in a humidifier 
chamber for 16-18hr. Sections were then washed three times in PBS and incubated 
in Alexa488 (green) or Alexa 594 (Red) (Molecular Probes, Oregon, USA) labelled 
secondary antibodies (Table 1) diluted in blocking solution for 1 hr at RT. Finally, 
sections were washed three times in PBS, mounted in Vectashield containing DAPI 
(Vector Labs) and images captured by an Axiocam HRc, using Axiovision 4 software 
(all from Zeiss). Negative antibody controls (primary antibody omitted) were included 
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in each run and used to set the background threshold intensity for each antibody and 
each species. 
 
Protein extraction and western blotting 
Six intact controls and 6 DC injured rats/mice were killed at 8 dpl by intraperitoneal 
injection of Euthatol (Sigma). The T8 lesion site was isolated (lesion site + 3 mm of 
cord either side of the lesion epicentre for rats and 2 mm either side of the lesion 
epicentre for mice were removed and immediately snap frozen in liquid nitrogen. To 
determine the levels of wound healing/angiogenic proteins in mice and rat SCI, 
tissues were homogenised in ice-cold lysis buffer (1M Tris HCL; pH 7.4, 5M NaCl, 
0.5M EDTA, 0.25M EGTA, 1% NP-40 (Sigma)) containing protease inhibitor cocktail 
(Sigma) and clarified by centrifugation at 13,000 x g for 30 min at 4⁰C. Protein 
concentration was normalised using a calorimetric protein assay according to the 
manufacturer’s instructions (Bio-Rad, Hertfordshire, UK). Total protein (40µg) from 
each sample was mixed with 2 x Lammelli buffer (Sigma), boiled for 4 min and 
loaded onto pre-prepared 12% Tris-glycine SDS-PAGE gels. Resolved proteins were 
transferred onto Immobilon-P polyvinylidene fluoride (PVDF) membranes (Millipore, 
MA, USA) and blocked in 5% non-fat milk solution for 30 min before incubation with 
the same primary antibodies as used for immunohistochemistry (Table 1) overnight 
at 4°C with constant agitation. Membranes were washed three times in Tris-buffered 
saline containing Tween 20 (TBST) before incubation with the appropriate HRP-
conjugated secondary antibodies (Table 1) for 1hr at RT. Protein bands were 
detected using an enhanced chemiluminescence (ECL) system according to the 
manufacturer’s instructions (GE Healthcare). Membranes were stripped in a low pH 
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stripping buffer (25mM glycine-HCl, pH2, 1% SDS (Sigma)) and re-probed as 
required.  
Bands of interest detected by western blot were quantified using densitometry 
after scanning membranes into Photoshop (keeping scanning parameters the same 
for all blots), and analysed using the built-in gel plotting macros in ImageJ (NIH, 
USA). Since antibody cross specificities may vary between mouse and rat tissue, we 
first normalised densitometric values to those obtained with intact controls from each 
species and then three separate blots from three independent experiments were also 
normalised to α-tubulin loading control densities for each species. The results are 
then presented as mean ± SEM. 
 
Image analysis 
Prior to image analysis, the identity of each section was blinded and randomised by 
a second investigator. To eliminate sample bias caused by the variation in the size of 
the wound cavity in sections at different wound depths and the relative sizes of rats 
and mice, cavity sizes from sections taken at similar depths in each animal were 
compared and quantified  
 
Lesion cavity area. Although sections throughout the lesion cavity were stained to 
measure the lesion cavity area (Fig. 1), the middle three sections through each 
lesion cavity, determined by cutting sections from the start to the end of the DC 
lesion  (n = 6 rats/mice/time-point) was used to measure lesion cavity area using 
ImagePro Analyzer.  
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Relative fluorescent staining intensity. All photomicrographs were taken at x 5 
magnification with the Zeiss Axioplan 2 fluorescent microscope using the same 
standardised exposure settings throughout for each antibody. Controls from each 
species where primary antibody was omitted were used to set the background 
threshold for each species. The middle three sections through each cavity was used 
to record positive immunostaining for each antibody in pixel counts from a set area of 
1.335µm x 1.335µm that included the lesion site. Using ImageJ (NIH, USA), images 
were thresholded and the mean integrated intensity of pixels/unit area for each 
antibody was recorded.  
 
Quantification of spared axon density in the dorsal funiculus. Photomicrographs of 
the dorsal funiculus were captured using the Zeiss Axioplan 2 fluorescent 
microscope as described above. Using ImageJ (NIH) the relative intensity of NF200+ 
staining was measured in the traced area of the entire dorsal funiculus after 
normalisation of the background intensity, obtained with omission of primary 
antibody controls for each species, was subtracted from the positive intensity value. 
Automatic thresholding for each image using ImageJ was performed to determine 
the threshold for specific immunoreactivity and pixel intensities above threshold 
levels were recorded. 
 
Functional test procedures 
Thermal sensitivity. Using established methods of Plantar heat sensitivity tests 
described previously (Detloff et al., 2012; Hargreaves et al., 1988; Lindsey et al., 
2000), animals were acclimatised 1-wk before surgery and on -1, 0 (2hr after 
surgery), 7, 14, 21 and 28 dpl data were collected at the same time of day to ensure 
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consistency (n = 12 rats/mice (6 sham, 6 DC injured)). Animals were acclimatised in 
clear Perspex compartments (230mm x 170mm) for 5 min before testing 
commenced. Once the plantar surface of the hind limbs was placed on the glass with 
weight support and the animal was stationary, the infra-red (IR) heat source (Harvard 
Apparatus, Massachusetts, USA) was placed directly beneath the centre of the 
plantar surface and the beam activated to produce a thermal stimulus to start the 
trial. The reaction time of paw withdrawal was recorded for 5 separate tests for each 
hind limb with a 30s interval before re-testing on the same paw. The middle three 
scores for the hind limbs were averaged to produce a single score for each animal 
and presented as mean ± SEM. 
 
Mechanical allodynia. To quantify mechanical sensitivity, hindlimb withdrawal 
responses were quantified using Von Frey hair filament tests. Animals were placed 
in the Perspex compartment, supplied with food for distraction and allowed to 
acclimatise for 10 min. Monofilaments representing specific gram weight forces 
(Stoelting Europe, Dublin) were applied to the plantar surface of each hind paw 
between the foot pads (previously marked with permanent marker) for a 1-2s period 
in a steady manner. A withdrawal response of the hind limb to the particular 
monofilament was recorded as a positive response, while a failure to elicit a 
withdrawal response was recorded as negative. A total of 10 separate trial 
responses were recorded for each hind limb with a 30s interval between each 
recording. Monofilament scores from both hind limbs were averaged to the lowest 
monofilament level used at which 50% or more trials were positive and converted to 
gram force and presented as mean ± SEM. 
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Statistical analysis 
Means ± SEM were determined and all statistical comparisons were made in 
SPSS (IBM) using a one-way analysis of variance (ANOVA) assuming unequal 
variances followed by post-hoc testing with Dunnett’s method to test for statistical 
differences. 
 
 
RESULTS 
Characterisation of the DC scarring response to injury 
GFAP+ astrocytes were abundant in the neuropil, about the lesion site and invading 
the lesion core in mice (arrows; Fig. 2A and inset). In rats, fewer GFAP+ astrocytes 
were localised within the lesion and none were seen in the lesion core (Fig. 2B and 
inset). Fibronectin+ ECM material filled the lesion core in mice (Fig. 2C and inset), 
whereas little or none was present in rat SCI wounds (Fig. 2D and inset). Low 
numbers of CD68+ cells were present in both mice (Fig. 2E and inset) and rats (Fig. 
2F and inset), and low levels of NG2 were also present in the SCI wounds of both 
species. 
 
Acute cavity development 
Little or no difference in gross anatomy was observed in intact mouse and rat T8 
spinal cord segments (Fig. 3A and B). At 2 dpl, there was disruption to the normal 
architecture of the cord in the two species (Fig. 3C and D), and in rats a lesion cavity 
had begun to develop (Fig. 3D). Differences between mice and rat DC lesion sites 
were more obvious at 8 dpl, with tissue disruption in the cord in mice (Fig. 3E) and 
the development of an obvious wound cavity in rats filled with haematogenous cells, 
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debris, fibrous material interspersed with small empty cavity areas (Fig. 3F). Both 
type I and II cavities were present in rat cords at 8 dpl. By 15 dpl, scar tissue had 
formed at the SCI site but no lesion cavities had developed in mouse cords (Fig. 3G) 
while, in rats the wound had expanded both rostrally and caudally and contained 
Type I cavities consisting haematogenous cells (Fig. 3H).  
Mean wound cavity area in the rat was 21 x 10⁴ ± 7.5 x 104 µm² and 26 x 10⁴ 
± 4 x 104 µm² at 8 and 15 dpl, respectively (Fig. 3I). These results confirm that wound 
cavitation is extensive in the rat cord after DC lesion while in the mouse cavities do 
not develop.   
 
Laminin deposition in DC lesions 
In the intact cord, meningeal and vascular basal laminae were laminin+ in both mice 
and rats (Fig. 4A and B). At 2 dpl, the levels of laminin deposition did not change 
significantly, compared to that observed at 0 dpl in both species (Fig. 4C and D), but 
was enhanced in mice compared to rats in the glia limitans externa (GLE), vascular 
basal lamina, ECM filled lesion core, lining of Type I cavities and the glia limitans 
accessoria (GLA) at 8 dpl (Fig. 4E and F). Enhanced levels of laminin+ 
immunoreactivity in the GLE, basal lamina of the blood vessels, ECM of the lesion 
core and the GLA remained in 15 dpl mouse lesions (Fig. 4G). In rats at 15dpl, 
laminin+ immunoreactivity was primarily associated with the GLE and GLA (Fig. 4H), 
while the laminin+ immunoreactivity did not change significantly in the GLE of both 
mouse and rat. 
Quantification of laminin immunoreactivity reflected these changes, 
demonstrating significantly enhanced levels of laminin in DC wounds in mice 
compared to rats at 8 dpl (16 x10⁴ ± 5.5 x 104 in mice compared to 10 x 10⁴ ± 4.0 x 
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104 pixels in rats, P<0.0001) and 15 dpl (14 x 10⁴ ± 1.6 x 104 in mice compared to 11 
x 10⁴ ± 2.1 x 104 pixels in rats, P<0.0001) (Fig. 4I). These results demonstrate that in 
mice compared to rats, SCI sites have greater neovascularisation, do not cavitate 
and have higher levels of ECM molecules.   
 
Comparison of factors in rat and mouse DC wounds at 8 dpl 
Since our results thus far demonstrated the greatest differences in cavitation and 
laminin immunoreactivity at 8 dpl, we selected this time point for further analysis 
detailed below. 
1. Angiogenic growth factors. VEGF-A (Fig. 5A-C, Table 2), TGFβ-2, PDGF-BB, 
FGF2, angiogenin and angiopoeitin-1 (Table 2) were all significantly higher in mouse 
SCI sites compared to rats. In the mouse, these growth factors were 
immunohistochemically localised within the lesion site and surrounding neuropil and 
up to 5 mm either side of the lesion epicentre (Fig. 5A), whereas in rats they were 
absent from the lesion site with low levels of immunohistochemistry in the 
surrounding neuropil.  
 Western blotting and subsequent densitometry demonstrated that VEGF-A 
(Fig. 5D, Table 3) and TGF-β2, PDGF-BB, FGF2, angiogenin and angiopoeitin-1 
(Table 3) levels were significantly higher in mice compared to rats.  
  
2. MMP and TIMP. MMP-1 (Fig. 6A-C, Table 4), MMP-2 and MMP-9 
immunoreactivity (Table 4) were significantly higher in mouse lesion sites compared 
to the rat and similarly distributed in the lesion site and the surrounding neuropil.  
Western blot densitometry of MMP showed that MMP-1 (Fig. 6D and E, Table 
5), MMP-2 and MMP-9 levels (Table 5) were greater in mouse lesion sites compared 
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to rats. In contrast, TIMP-2 immunohistochemical (Fig. 7A-C, Table 4) and western 
blot (Fig. 7D and E, Table 5) levels were low in mouse lesion sites compared to the 
rat, with immunoreactivity distributed in the surrounding neuropil of the rat cord but 
absent in the wound cavity.  
 
3. ECM/scarring-related molecules. Sema-3A immunoreactivity was absent in mice 
and was high in rat lesion cavities and the peri-lesion neuropil (Fig. 8A-C, Table 6). 
Conversely, collagen-1 immunoreactivity was highly upregulated in the mouse 
compared to rat lesion sites (Table 6) and its distribution mirrored that of laminin, i.e. 
within the lesion in mice and localised to the GLA in the rat (not shown). The cell 
adhesion molecule, PECAM-1, was also significantly higher in mice compared to rat 
SCI wounds (Table 6), localised to the lesion site and peri-lesion neuropil (not 
shown). Western blotting and densitometry confirmed that Sema-3A (Fig. 8D and E, 
Table 7) and PECAM1 (Table 7) levels were significantly higher in rats compared to 
mice.  
These results demonstrate fundamental differences in healing of SCI wounds 
in mice compared to rats, i.e. aggressive wound healing in mice marked by 
increased deposition of matrix proteins, pro-angiogenic growth factors correlated 
with raised levels of MMP and reduced TIMP titres.  
 
Changes in carbonic anhydrase-X after SCI 
CA10 immunoreactivity was seen in the lesion site and peri-lesion neuropil in mice 
and rats (Fig. 9A and B). At 8 dpl, there was significantly higher levels of CA10 in 
rats compared to mice (5.6 x10² ± 2.5 x 102 pixels in rats compared to -7.6 x 102 ± 
1.6 x 102 pixels in mice, P<0.001, Fig. 9C). These results were confirmed by western 
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blot, demonstrating that the protein levels of CA10 were significantly higher in rat 
compared to mouse DC lesions (5.5 x10⁴ ± 2.0 x 104 pixels in rat compared to -5.5 x 
104 ± 1.8 x 106 in mice, P<0.021, Fig. 9D and E). These results show that increased 
levels of CA10 are observed after DC injury in rats.  
 
Greater sparing of NF200+ DC axons in mice compared to rats  
Spared axons in the DC of mice and rats after injury were assessed by calculating 
the area occupied by NF200 labelling in the whole dorsal funiculus (Bouhy et al., 
2011). In spinal segments T7 (above lesion) and T9 (below lesion), normal basal 
levels of NF200+ Immunostaining was observed in control mice (Fig. 10A and B, 
respectively) and rats (Fig. 10E and F, respectively), in the CST and in interneurons 
and their axons in the superficial dorsal horn. After DC injury in mice, NF200 
immunohistochemistry was significantly reduced in the CST at T7 and T9 compared 
to intact controls, indicative of retrograde axonal dyeback of axons that originate 
from the motor cortex, respectively (Fig. 10C and D). In rat lesioned DC, reduced 
NF200 immunohistochemistry was observed in spinal segments in the CST from T7 
and T9 (Fig. 10G and H), compared to control rats. The reduction in NF200 
immunoreactivity in the DC was greater in rat T7 (65 ± 4% in rat versus 42 ± 3% in 
mice, P<0.01) and T9 (45 ± 3% in mice versus 20 ± 4% in rat, P<0.01) segments 
(Fig. 10I) compared to mice. 
Similar changes in PKC-γ immunostaining were also observed in DC injured 
dorsal funiculus of mice and rats (not shown). PKC-γ is an isotope of the classical 
PKC subfamily, which is solely expressed in the brain and spinal cord and 
localisation is restricted to neurons (Saito and Shirai, 2002). This restriction allows 
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determination of axonal sparing after sub-acute DC between mice and rats (Barritt et 
al., 2006).  
 
Behavioural analysis 
The response to thermal stimuli in both rats and mice were significantly impaired 2 hr 
after DC injury compared to sham-treated control animals (Fig. 11A and B). For 
example, the reaction time (paw withdrawal latency) was delayed by 3.38s in mice 
(P<0.042) and by 5.63s in rats (P<0.042). However, by 7dpl the response to thermal 
stimuli had returned to sham-treated control levels and showed no further differences 
in withdrawal latency over the course of the experimental time-period of 28dpl (Fig. 
11A and B). Unlike thermal responses, mechanical allodynia responses were not 
significantly different in mice or rats, with or without DC injury and did not vary over 
the experimental time-period (not shown). These results indicate that despite the 
presence of a large wound cavity in rats, DC injury did not affect responses to 
mechanical stimuli but temporarily affected responses to thermal stimuli in the early 
stages after DC injury. However, within 7 dpl, animals regained normal function 
response times and were no different to those observed in sham-treated control 
animals.  
 
 
DISCUSSION 
We report here that significant differences exist in the acute SCI response in mice 
compared to rats and that cavitation only develop in rats at early time points. In rats, 
the wound cavity expands over time and by 15dpl large Type I cavities are present, 
filled with haematogenous macrophages. In contrast, the mouse lesion site is in-filled 
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and rich in the ECM molecules laminin and collagen, together with pro-angiogenic 
and pro-wound healing factors. In addition, levels of axon growth inhibitory Sema-3A 
and anti-proteolytic TIMP-2 were significantly higher in rat than in mouse SCI sites 
indicating an environment less conducive to axon growth and wound remodelling. 
These results support our contention that an enhanced healing response in mice is 
associated with suppressed cavitation, a response that is facilitated by high levels of 
pro-angiogenic and pro-wound healing factors. Greater numbers of NF200+ and 
PCK-γ+ axons were spared in mice compared to rats, suggesting that cavitation is 
detrimental to axon integrity. Nonetheless, the presence of a large cavity in rats had 
no effect on mechanical allodynia but thermal allodynia was affected in both mice 
and rats immediately after injury, recovering to normal levels within 7dpl. 
  
Cavitation 
Although small severity-dependent injury cavities have been reported in mouse SCI 
sites, our results confirm those of others that ECM deposition without cavitation is a 
more characteristic response (Bilgen et al., 2007; Inman and Steward, 2003). By 
contrast, rat SCI wounds cavitated by 8dpl and by 15dpl when a large Type I cavity 
had formed which extended rostrally and caudally from the injury epicentre, filled 
with haematogenous macrophages and cellular debris. Cavities may develop after 
vascular regression and endothelial cell loss (Casella et al., 2006; Loy et al., 2002) 
and their expansion may be exacerbated by hypoxia, necrosis, apoptosis and 
increased vascular permeability (disruption of the blood spinal cord barrier (BSCB)). 
Demyelination and neuronal degeneration occur in the surrounding neuropil as the 
cavity expands (Berry et al., 2008; Blight, 2000; Casella et al., 2006; Fassbender et 
al., 2011; Hunt et al., 2002; Mautes et al., 2000; Sandvig et al., 2004; Whetstone et 
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al., 2003). Cavities may expand as damaged tissues are removed by inflammatory 
macrophages and microglia, explaining the beneficial effects of immunosuppressive 
therapies which probably maintain structural and functional integrity of the spinal 
cord (Blight, 1994; Giulian and Robertson, 1990; Guth et al., 1994; Popovich et al., 
1999).  
Cavitation in the human condition of post-traumatic syringomyelia is a 
potentially disastrous complication of SCI, causing intractable pain and loss of upper 
extremity function, and may be life-threatening if the syrinx extends rostrally into the 
brainstem (Biyani and el Masry, 1994; Edgar and Quail, 1994). Currently, there is no 
cure for this condition and therefore understanding the differential factors regulating 
cavitation in mice and rats may lead to the development of potential therapies for this 
debilitating condition. 
 
Inflammatory responses 
Although Sroga et al (2003) reported similar responses of macrophages and 
microglia in mouse and rat SCI sites, accumulation of T-cells at the wound peaks in 
rats between 3 and 7dpl and declines by 50% over the next three weeks, while T-cell 
entry is not evident in the mouse until after 14dpl (Sroga et al., 2003). Dendritic cells 
(normally absent in control rat and mouse spinal cords) infiltrate SCI wounds with T-
cells in rats but not in mice, suggesting another species difference in inflammatory 
reactions to SCI (Sroga et al., 2003). Antigen-presenting dendritic cells can both 
activate or kill T-cell (Bernstein et al., 1986) and their accumulation in a SCI wound 
could be detrimental by stimulating infiltration of T-cells into the cord, or protective by 
removing cytotoxic T-cells. Furthermore, cells resembling lymphocytes but not 
expressing lymphocyte markers, a phenotype characteristic of fibrocytes, which are 
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specialised blood-borne cells, involved in wound healing and immunity, are also 
present only in mice (Chesney and Bucala, 1997; Sroga et al., 2003). Although these 
differential inflammatory responses may explain why mice do not cavitate, it remains 
to be determined whether they contribute to the different injury responsive molecular 
profiles observed between the two species.   
 
Angiogenic growth factors 
Angiogenesis is beneficial in reducing secondary axonal damage after SCI, 
protecting against ischemia by increasing oxygen delivery and nutrients to sites of 
regeneration and removal of metabolic waste (Loy et al., 2002; Lutton et al., 2012). 
After traumatic SCI in the two species, blood vessels fracture leading to disruption of 
the blood-spinal cord barrier (BSCB) and exposure of the neuopil to the damaging 
effects of inflammatory macrophages and microglia (Noble and Wrathall, 1985; 
Schlosshauer, 1993). Our mouse SCI wounds were filled with pro-angiogenic/pro-
wound healing factors that were largely absent from rat lesion sites. The higher 
levels of laminin and collagen in mouse lesion sites after SCI provide essential 
matrix scaffolds (Okada et al., 2007) for angiogenesis and tissue remodelling, which 
promote better wound healing properties. The expression of several potent 
angiogenic factors were more positively modulated in the injured mouse versus rat 
cord, including VEGF-A, angiogenic, and this was reflected by a more robust 
angiogenic response. Other factors important to the healing process were also 
higher in mouse compared to rat SCI wounds. For example, FGF2, which exerts 
neurotrophic and neurite outgrowth properties in culture (Moftah, 2007) also 
contributes to wound healing (Carmeliet and Jain, 2000; Chung and Ferrara, 2010; 
Hiraoka et al., 1998).  
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The high levels of PECAM1 in mouse SCI wounds may promote angiogenesis 
(Newman, 1997) and also remove aged neutrophils, aiding in leukocyte migration 
and activating integrins, thereby contributing to wound-healing and revascularisation 
after injury (Goussev et al., 2003; Newman, 1997; Whetstone et al., 2003). 
Angiopoietin-1 induces PECAM1 and tight junction proteins such as occludin and 
ZO-2 which restore BSCB integrity by limiting vascular permeability (Gamble et al., 
2000; Hori et al., 2004; Lee et al., 2009), strengthening paracellular interactions and 
reducing the number and size of endothelial gap junctions (Baffert et al., 2006; Wong 
et al., 1997). Angiogenin on the other hand, has definitive neuroprotective properties 
on motor neurons (Kieran et al., 2008), and may provide similar neuroprotection in 
our SCI wounds. VEGF is also likely to contribute to better wound healing in the 
mouse since it modulates inflammatory reactions, creating a microenvironment that 
contributes to axon preservation and sprouting through maturation, stability and 
wound healing properties (Chung and Ferrara, 2010; Khalil et al., 1989; Lutton et al., 
2012).  
 
MMP and TIMP 
Enhanced levels of MMP-2 and MMP-9 are detectable in the acute phase after SCI, 
facilitating inflammatory cell infiltration and permeability of BSCB (Biddison et al., 
1997; Delclaux et al., 1996; Gronski et al., 1997; Rosenberg, 1995). Thus, treatment 
with either MMP inhibitors or neutralizing antibodies to MMP can protect against 
BSCB breakdown and prevent inflammatory cell infiltration (Romanic et al., 1998; 
Rosenberg, 1995). The high levels of MMP and low levels of TIMP observed here in 
the mouse SCI wounds is thought to be conducive to wound healing since MMP-1, -
2 and -9 are all required during angiogenesis and are detected at high levels in sites 
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of angiogenesis (Hiraoka et al., 1998; Iwasaka et al., 1996; Zucker et al., 1995). 
MMP-mediated proteolysis thus facilitates invasion of endothelial cells into the 
wound matrix, generates ECM degradation products that are chemotactic for 
endothelial cells and releases ECM bound growth factors to aid the healing process. 
 
Hypoxia and angiogenesis  
Although hypoxia regulates angiogenesis (Potter and Harris, 2004), the higher levels 
of carbonic anhydrase observed in rats in our experiments did not correlate with this 
assertion. Despite CNS expression of CA10 (Okamoto et al., 2001; Taniuchi et al., 
2002), other isoforms of carbonic anhydrase contribute to neuronal death and blood-
brain barrier (BBB) disruption after brain and retinal injury (Gao et al., 2007; Guo et 
al., 2012). Higher CA10 levels seen in the rat may, therefore, act similarly causing an 
increase in BBB permeability, neuronal death and oedema, all of which are 
detrimental to recovery from SCI. 
 
Semaphorin-3A 
We found raised levels of Sema-3A in and around the lesion site after SCI in rats 
while Sema-3A was almost completely absent in mouse suggesting that Sema-3A 
deposition hinders wound healing and contributes to the cavity development. Sema-
3A has multiple functions including blocking axon regeneration after binding to its co-
receptor; NP1 on axonal growth cones (Schlomann et al., 2009; Shelly et al., 2011), 
while inhibition of Sema-3A is a potential therapeutic treatment for promoting axon 
regeneration after SCI (Kaneko et al., 2006; Mire et al., 2008). In addition, Sema-3A 
binds VEGF and its plexin receptors and directs angiogenesis (Neufeld et al., 2005; 
Soker et al., 2002; Tamagnone et al., 1999).  
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Axonal sparing and behavioural testing 
Our assumptions that axonal sparing would be enhanced in mice due to the lack of 
cavitation was borne out by the observation of the significantly lower reduction in 
PKC-γ immunoreactivity seen in the mouse compared to the rat CST spinal 
segments above and below the lesion. These results suggest that axonal dieback 
and Wallerian degeneration are increased in rats compared to mice and may be 
caused by the extension of the cavity both rostrally and caudally in rat SCI sites. 
However, reductions in PKC-γ immunoreactivity indicating relative axon sparing in 
the mouse, did not correlate with behavioural deficits in injured animals assessed 
using IR heat and Vonfrey hair filament tests. Hill et al (2009) demonstrated using a 
LISA-Vibraknife that generates precise dorsal lacerations, that injury depths between 
0.5-1.0mm did not affect behavioural tests similar to those used in our study (Hill et 
al., 2009). However, since detrimental effects were only observed beyond a DC 
lesion depth of 1.1mm, lesions deeper than 0.8mm may be required to obtain 
behavioural deficits after DC injury. However, other studies using weight drop 
devices that produce more overt injuries than DC crush have shown that lesion 
severity correlates with the extent of behavioural deficits in mouse SCI models 
(Farooque, 2000; Ma et al., 2001; Seki et al., 2002).  
Although we have used an inbred mouse (C57Bl6) and outbred rat (Sprague-
Dawley) strain to investigate cavitation, equivalent responses to DC injury have been 
observed in other outbred rat strains such as Long Evans and Wistar rats (Jimenez 
et al., 2005; Byrnes et al., 2010; Schwartz et a., 1999; Poon et al., 2007; Lagord et 
al., 2002; Figley et al., 2014) as well as inbred strains such as Lewis rats (Sroga et 
al., 2003). The extent of cavitation however, is dependent on the severity of the initial 
injury (Poon et al., 2007). Furthermore, there is no consistency across inbred and 
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outbred strain to indicate that cavitation would be different in one group of animals 
versus the other group. For example, SCI in inbred and outbred strains of mice that 
are either resistant or susceptible to excitotoxicity all showed increases in lesion size 
over the first 7 days followed by decreases in cavity size and wound-healing from 7 
to 56 days, although animals susceptible to excitotoxicity showed larger lesion sizes 
across all strains (Inman et al., 2002). Therefore, our results are valid across a range 
of rat and mouse strains and highlights the differences in cavity formation, matrix 
deposition and wound healing responses.  
 
Conclusion 
In conclusion, differences do exist between mice and rats in cavity formation, matrix 
deposition and pro-angiogenic protein levels after DC injury, indicating that mice 
have a more robust angiogenic and wound healing response to SCI that is 
associated with less cavitation and resultant axon sparing. Despite losses in PKC-γ 
immunoreactivity in DC above and below the lesion in both species, only the 
response to thermal stimuli was reduced 2 hr after injury with response times 
returning to normal within 7 dpl compared to sham controls in mice and rats. Our 
results support the hypothesis that the absence of cavitation in mice is due to an 
adequate balance between angiogenesis, wound healing and scar deposition 
compared to rats that fail to lay down ECM after sub-acute SCI. Our results indicate 
key differences between the wound healing response in mice compared to rats that 
requires further investigation. 
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FIGURE LEGENDS 
Fig. 1. Area of acute DC wound cavity at increasing depths from the surface of the 
spinal cord (n = 6 rats represented by different symbols shown in the key). Three 
sections chosen at different depths through the lesion were immunostained for 
laminin and GFAP and used to measure the size of the cavity in 6 different animals 
in the rat.  
 
Fig. 2. Acute SCI response in mice and rats. Immunohistochemistry to show 
changes in GFAP (A and B), fibronectin (C and D), CD68 (E and F) and NG2 (G and 
H) at 8 dpl within and about DC lesions (* = lesion epicentre; scale bars in A-H = 200 
µm; arrows in A = GFAP+ astrocytes invading the lesion core; A-D and E-H are 
consecutive sections, respectively). 
 
Fig. 3. Histological differences in wound cavitation in mice and rats at 0 (A and B), 2 
(C and D), 8 (E and F) and 15 dpl (G and H). Rat lesion cavity area determined by 
haematoxylin and eosin staining of the middle section of each cavity between 0-
15dpl (I) (n = 6/group/time-point; * = lesion epicentre; scale bars in A-I = 200 µm; 
arrowheads in D, F and H = cell free areas in rat SCI cavities). 
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Fig. 4. Localisation of laminin in the lesion site over the 15 dpl time in DC lesions in 
mice and rats. Expression of laminin in intact controls (A and B) and at 2 (C and D), 
8 (E and F) and 15 dpl (G and H). Pixel intensities were calculated and average pixel 
counts were plotted showing significant differences in laminin expression between 
mice and rats (I) (n = 5/group/time-point; * = lesion epicentre; scale bars in A-H = 
200 µm; arrowheads = glia limitans externa (GLE); arrows = glia limitans accessoria 
(GLA); open arrows = blood vessels). 
 
Fig. 5. The localisation of VEGF-A at 8 dpl in DC lesions. Immunohistochemistry for 
VEGF-A in mice (A) and in rats (B) and the pixel intensities of VEGF-A+ fluorescence 
(C). Western blot (D) and densitometry (E) corroborated the immunohistochemistry 
results (α-tubulin was used as a protein loading control (F);  scale bars in A and B = 
200 µm). 
 
Fig. 6. The localisation of MMP-1 at 8 dpl after DC lesion. Immunohistochemistry for 
MMP-1 in mouse (A) and rat (B) and the pixel intensities of MMP-1+ fluorescence 
(C). Western blot (D) and densitometry (E) was used to corroborate the 
immunohistochemistry results (the same α-tubulin was used as a protein loading 
control as in Figure 4F; scale bars in A and B = 200 µm). 
 
Fig. 7. The localisation of TIMP-2 at 8 dpl in  DC lesions. Immunohistochemistry for 
TIMP-2 in mouse (A) and rat (B) and the pixel intensities of TIMP-2+ fluorescence 
(C). Western blot (D) and densitometry (E) corroborated the immunohistochemistry 
results (the same α-tubulin was used as a protein loading control as in Figure 4F;  
scale bars in A and B = 200 µm). 
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Fig. 8. The localisation of Sema-3A at 8  dpl in DC lesions. Immunohistochemistry 
for Sema-3A in mouse (A) and rat (B) and the pixel intensities of Sema-3A+ 
fluorescence (C). Western blot (D) and densitometry (E) corroborate the 
immunohistochemistry results (the same α-tubulin was used as a protein loading 
control as Figure 4F; scale bars in A and B = 200 µm). 
 
Fig. 9. The localisation of CA9, a marker of hypoxia after DC lesion at 8 dpl in mice 
and rats. (A) and (B) immunohistochemistry and (C) quantification of the CA9+ pixel 
intensities in the lesion site and peri-lesion neuropil in mice and rats. (D) Western 
blot and (E) densitometry from tissue lysates to demonstrate proteins levels of CA9 
in the DC lesion of mice and rats (scale bars in A and B = 200µm). 
 
Fig. 10. NF200 immunoreactivity as an indicator of axonal sparing at 8dpl after DC 
injury in spinal segments above and below the lesion. Representative NF200 
staining at T7 (above lesion) in mouse control (A) and injured (C) and at T9 control 
(B) and injured (D) cords. Representative NF200 staining at T7 in rat control (E) and 
injured (G) and at T9 control (F) and injured (H) cords. Quantification of the 
immunoreactivity (I) demonstrated that NF200 immunoreactivity was reduced in rats 
compared to mice at both T7 and T9 spinal segments. Scale bars = 200 µm. 
Diagram shows dorsal column and corticospinal tract axons quantified in (I).  
 
Fig. 11. Comparison of the behavioural deficits observed after T8 DC injury in mice 
and rats over time using IR plantar heat test. Quantification on the average reaction 
time before surgery (-1), 2 hours after surgery (0), 7, 14, 21 and 28 dpl showed 
significant differences in mice (A) and rats (B) at 0dpl only compared to control. 
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Table 1. List of antibodies used for this study 
 
 
Angiogenic/ wound healing-related 
proteins  
Dilution 
factor 
Species Supplier 
Primary Antibodies 
Laminin 1:200 (IHC-F), 
1:100 (WB) 
Rabbit Sigma, Poole, UK 
Fibroblast growth factor (FGF2) 1:200 (IHC-F, 
WB) 
Rabbit Selective Genetics 
Angiopoetin-1 1:200 (IHC-F), 
1:100 (WB) 
Rabbit Abcam, Cambridge, UK 
Semaphorin 3A 1:200 (IHC-F 
and WB) 
Rabbit Abcam, Cambridge, UK 
Vascular endothelial growth factor A 
(VEGF-A) 
1:400 (IHC-F), 
1:1000 (WB) 
Rabbit Abcam, Cambridge, UK 
Angiogenin 1:100 (IHC-F 
and WB)  
Rabbit Santa Cruz Biotechnology, 
Danvers, USA 
Tissue inhibitor of metalloproteinase-2 
(TIMP2) 
1:200 (IHC-F 
and WB) 
Rabbit Neomarkers 
Matrix metalloprotease-1 (MMP-1) 1:200 (IHC-F), 
1:100 (WB) 
Sheep Biogenesis 
Matrix metalloprotease-2 (MMP-2) 1:200 (IHC-F), 
1:100 (WB) 
Rabbit Chemicon International,  
Matrix metalloprotease-9 (MMP-9) 1:100 (IHC-F 
and WB) 
Rabbit Santa Cruz Biotechnology, 
Danvers, USA 
Platelet endothelial cell adhesion 
molecule (PECAM1; CD31) 
1:200 (IHC-F), 
1:100 (WB) 
Rabbit Santa Cruz Biotechnology, 
Danvers, USA 
Transforming growth factor β2 (TGFβ2) 1:200 (IHC-F 
and WB) 
Rabbit Santa Cruz Biotechnology, 
Danvers, USA 
Platelet-derived growth factor (PDGF-
BB) 
1:200 (IHC-F 
and WB) 
Rabbit Chemicon, 
Collagen-1 1:200 (IHC-F) 
 
Rabbit Abcam, Cambridge, UK 
Carbonic anhydrase X 1:100 (IHC-F), 
1:200 (WB) 
Rabbit Abcam, Cambridge, UK 
Protein kinase C 1:250 (IHC-F) 
 
Rabbit Abcam, Cambridge, UK 
α-tubulin 1:2000 (WB) 
 
Rabbit Abcam, Cambridge, UK 
Secondary antibodies    
Alex 488 anti-rabbit IgG 1:400 (IHC-F) 
 
Rabbit  
Alexa 488 anti-sheep IgG 1:400 (IHC-F) 
 
Sheep  
Horseradish peroxidase (HRP) 1:1000 (WB) 
 
Rabbit  
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Table 2. Mean fluorescence intensities of angiogenic growth factors in sections of spinal 
cord at 8 dpl after DC injury. 
 
Factor Mean Intensity (pixels) (± SEM) 
 
          Mouse                                 Rat 
P value 
VEGF-A 15 x102 ± 5 x102 -25x102 ± 7x102 P<0.0001 
TGFβ2 28 x 102 ± 6 x102 -8 x 102 ± 4 x 102 P<0.001 
PDGF-BB 31 x 102 ± 3 x 102 10 x 102 ± 4 x 102 P<0.002 
FGF2 6 x 102 ± 2 x 102 -8 x 102 ± 2.5 x 102 P<0.001 
Angiogenin 19.9 x 102 ± 3 x 102 10 x 102 ± 5.4 x 102 P<0.001 
Angiopoeitin-1 8 x 102 ± 3 x 102 -24 x 102 ± 9 x 102 P<0.002 
 
 
Table 3. Mean integrated density of angiogenic growth factors in mouse and rat SCI sites at 
8 dpl, determined by western blotting.  
  
Factor Mean integrated density (arbitrary units)  
(± SEM) 
           Mouse                             Rat 
P value 
VEGF-A 5 x 104 ± 0.8 x 104 -1 x 104 ± 0.6 x 104 P<0.039 
TGFβ2 2 x 104 ± 0.1 x 104 0.5 x 104 x 0.1 x 104 P<0.001 
PDGF-BB -9 x 104 ± 1.2 x 104 -13 x 104 ± 0.2 x 104 P<0.045 
FGF2 17 x 104 ± 5 x 104 1 x 104 ± 0.15 x 104 P<0.002 
Angiogenin 10 x 104 ± 0.2 x 104 -2 x 104 ± 0.12 x 104 P<0.033 
Angiopoeitin-1 4 x 104 ± 0.8 x 104 -3 x 104 ± 0.2 x 104 P<0.003 
 
Table 4. Mean fluorescence intensities of MMP and TIMP in sections of spinal cord at 8 dpl 
after DC injury 
  
Factor Mean intensity (pixels) (± SEM) 
 
          Mouse                              Rat 
P value 
MMP-1 16 x 102 ± 7 x 102 -44 x 102 ± 12 x 102 P<0.0001 
MMP-2 -19 x 102 ± 8 x 102 -13 x 102 ± 6 x 102 P<0.425 
MMP-9 12 x 102 ± 1.7 x 102 3 x 102 ± 2.9 x 102 P<0.007 
TIMP2 -37 x 102 ± 9 x 102 18 x 102 ± 5.9 x 102 P<0.001 
 
Table 5. Mean integrated density of angiogenic growth factors in mouse and rat SCI sites at 
8 dpl, determined by western blotting. 
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Factor Mean integrated density (arbitrary units)  
(± SEM) 
          Mouse                              Rat 
P value 
MMP-1 4.7 x 104 ± 0.05 x 104 1 x 104 ± 0.8 x 104 P<0.038 
MMP-2 7 x 104 ± 0.5 x 106 2.5 x 104 ± 0.05 x 106 P<0.05 
MMP-9 10 x 104 ± 0.25 x 106 6 x 106 ± 0.07 x 106 P<0.041 
TIMP2 -2 x 104 ± 1.1 x 106 5 x 104 ± 0.5 x 104 P<0.023 
 
Table 6. Mean fluorescence intensities of scarring and ECM-related molecules in sections of 
spinal cord at 8 dpl after DC injury. 
 
Factor Mean Intensity (pixels) (± SEM) 
 
          Mouse                                 Rat 
P value 
Sema-3A -23 x 102 ± 7.5 x 102 16 x 102 ± 7.6 x 102 P<0.001 
Collagen-I 20 x 102 ± 5 x102 -2 x 102 ± 8.5 x 102 P<0.001 
PECAM-1 23 x 102 ± 5.2 x 102 -6.7 x 102 ± 3.5 x 102 P<0.001 
 
Table 7. Mean integrated density of scarring and ECM-related molecules in mouse and rat 
SCI sites at 8 dpl, determined by western blotting. 
 
Factor Mean integrated density (arbitrary units)  
(± SEM) 
          Mouse                                 Rat 
P value 
Sema-3A -4 x 106 ± 1.8 x 106 27 x 106 ± 0.87 x 106 P<0.05 
Collagen-I 24 x 106 ± 6 x106 -3 x 106 ± 2 x 106 P<0.001 
PECAM-1 6 x 106 ± 0.28 x 106 0.5 x 106 ± 0.01 x 106 P<0.037 
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HIGHLIGHTS 
• Cavitation is absent in the mouse after SCI while rats cavitate 
• Absence of wound cavitation in mice correlate with increased wound healing 
factors 
• Absence of cavities in mice correlates with enhanced axon sparing 
• Robust wound healing in mice abrogates wound cavities 
 
 
 
